December 03, 2024
2 min watch
Save
VIDEO: Orasis closes $78 million in financing
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Paul Smith of Orasis Pharmaceuticals announces the closing of a $78 million financing round that will help the company move toward the launch of Qlosi for presbyopia.
In addition, Smith discussed a partnership with Optus Pharmaceutical, a pharmaceutical company based in South Korea.
“The aspiration is to continue expanding into other key jurisdictions around the world, and we will be reporting on those as they develop in the coming months,” he said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Smith reports being president and chief operating officer of Orasis Pharmaceuticals.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.